Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
株式のランク #509
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
株価
$7.88
最終同期: 2026-08-12
時価総額
$50.25B
変化(1日)
-1.11%
変化(1年)
-9.73%
CN
取引 Jiangsu Hengrui Medicine Co., Ltd. (600276)

カテゴリー

Jiangsu Hengrui Medicine Co., Ltd.(600276)の配当利回りの履歴
Jiangsu Hengrui Medicine Co., Ltd.(銘柄コード: 600276)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Jiangsu Hengrui Medicine Co., Ltd.(600276)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)